88 FR 248 pgs. 89696-89697 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—CE22-003, Rigorously Evaluating Programs and Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Closed Meeting
Type: NOTICEVolume: 88Number: 248Pages: 89696 - 89697
Pages: 89696, 89697FR document: [FR Doc. 2023-28616 Filed 12-27-23; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE22-003, Rigorously Evaluating Programs and Policies To Prevent Child Sexual Abuse (CSA); Amended Notice of Closed Meeting
Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE22-003, Rigorously Evaluating Programs and Policies to Prevent Child Sexual Abuse (CSA); April 11, 2024, 8:30 a.m.-5 p.m., EDT, videoconference, in the original Federal Register notice. The meeting notice was published in the Federal Register on November 2, 2023, Volume 88, Number 211, page 75287.
The notice is being amended to change the start time to 10:30 a.m. The notice should read as follows:
Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-CE22-003, Rigorously Evaluating Programs and Policies to Prevent Child Sexual Abuse (CSA).
Date: April 11, 2024.
Time: 10:30 a.m.-5 p.m., EDT.
The meeting is closed to the public.
FOR FURTHER INFORMATION CONTACT:
[top] Aisha L. Wilkes, M.P.H., Scientific Review Officer, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341.
The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-28616 Filed 12-27-23; 8:45 am]
BILLING CODE 4163-18-P